(S)-nicotine multiple interactions EXP 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of IRAK1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of IRAK1 mRNA] CTD PMID:22206623 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression EXP 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions EXP 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 17alpha-ethynylestradiol decreases expression ISO Irak1 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of IRAK1 mRNA CTD PMID:17108234 17beta-estradiol affects expression ISO IRAK1 (Homo sapiens) 6480464 Estradiol affects the expression of IRAK1 mRNA CTD PMID:21826169 2-amino-2-deoxy-D-galactopyranose multiple interactions EXP 6480464 [lipopolysaccharide more ... CTD PMID:28213090 2-methylcholine affects expression ISO IRAK1 (Homo sapiens) 6480464 beta-methylcholine affects the expression of IRAK1 mRNA CTD PMID:21179406 3,3',4,4',5-pentachlorobiphenyl increases expression ISO IRAK1 (Homo sapiens) 6480464 3 more ... CTD PMID:35618242 3,3',5,5'-tetrabromobisphenol A increases expression ISO IRAK1 (Homo sapiens) 6480464 tetrabromobisphenol A results in increased expression of IRAK1 mRNA CTD PMID:25461914 5-fluorouracil increases expression ISO IRAK1 (Homo sapiens) 6480464 Fluorouracil results in increased expression of IRAK1 mRNA CTD PMID:15109396 5-fluorouracil affects response to substance ISO IRAK1 (Homo sapiens) 6480464 IRAK1 affects the susceptibility to Fluorouracil CTD PMID:15067352 acrylamide increases expression ISO Irak1 (Rattus norvegicus) 6480464 Acrylamide results in increased expression of IRAK1 mRNA CTD PMID:28959563 arsenous acid decreases expression ISO IRAK1 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of IRAK1 mRNA CTD PMID:23911876 atorvastatin calcium multiple interactions ISO IRAK1 (Homo sapiens) 6480464 [Atorvastatin co-treated with Enalapril] results in decreased expression of IRAK1 mRNA and [Atorvastatin co-treated with Telmisartan] results in decreased expression of IRAK1 mRNA CTD PMID:20524934 atrazine multiple interactions ISO IRAK1 (Homo sapiens) 6480464 [Atrazine co-treated with Arsenates] results in increased expression of IRAK1 mRNA CTD PMID:18585445 atrazine decreases expression ISO IRAK1 (Homo sapiens) 6480464 Atrazine results in decreased expression of IRAK1 mRNA CTD PMID:22378314 auranofin multiple interactions EXP 6480464 Auranofin inhibits the reaction [lipopolysaccharide A results in increased degradation of IRAK1 protein] CTD PMID:17034761 benzo[a]pyrene affects expression ISO IRAK1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the expression of IRAK1 mRNA CTD PMID:21873647 benzo[a]pyrene affects methylation ISO IRAK1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of IRAK1 exon CTD PMID:27901495 benzo[a]pyrene increases methylation ISO IRAK1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of IRAK1 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO IRAK1 (Homo sapiens) 6480464 7 more ... CTD PMID:20018196 bisphenol A affects expression ISO IRAK1 (Homo sapiens) 6480464 bisphenol A affects the expression of IRAK1 mRNA CTD PMID:21826169 and PMID:30903817 bisphenol A multiple interactions ISO IRAK1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of IRAK1 gene CTD PMID:31601247 bisphenol A decreases expression ISO Irak1 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of IRAK1 mRNA CTD PMID:33296240 bisphenol A increases expression ISO Irak1 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of IRAK1 mRNA CTD PMID:25181051 bortezomib decreases expression ISO IRAK1 (Homo sapiens) 6480464 Bortezomib results in decreased expression of IRAK1 mRNA CTD PMID:20471514 cadmium atom multiple interactions ISO IRAK1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IRAK1 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions EXP 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of IRAK1 mRNA CTD PMID:19840844 cadmium dichloride multiple interactions ISO IRAK1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IRAK1 mRNA CTD PMID:35301059 cadmium selenide multiple interactions ISO IRAK1 (Homo sapiens) 6480464 [cadmium selenide co-treated with zinc sulfide] results in increased expression of IRAK1 mRNA CTD PMID:22342292 caffeine multiple interactions EXP 6480464 [Caffeine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 cannabidiol multiple interactions EXP 6480464 Cannabidiol inhibits the reaction [lipopolysaccharide and E coli O55-B5 results in increased degradation of IRAK1 protein] CTD PMID:19910459 carbamazepine affects expression ISO IRAK1 (Homo sapiens) 6480464 Carbamazepine affects the expression of IRAK1 mRNA CTD PMID:25979313 carbon nanotube decreases expression EXP 6480464 Nanotubes and Carbon analog results in decreased expression of IRAK1 mRNA CTD PMID:25620056 CGP 52608 multiple interactions ISO IRAK1 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to IRAK1 gene] CTD PMID:28238834 cobalt dichloride increases expression ISO Irak1 (Rattus norvegicus) 6480464 cobaltous chloride results in increased expression of IRAK1 mRNA and cobaltous chloride results in increased expression of IRAK1 protein CTD PMID:21925238 cobalt dichloride decreases expression ISO IRAK1 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of IRAK1 mRNA CTD PMID:19320972 and PMID:19376846 copper atom multiple interactions ISO IRAK1 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which affects the expression of IRAK1 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO IRAK1 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which affects the expression of IRAK1 mRNA CTD PMID:30911355 copper(II) sulfate decreases expression ISO IRAK1 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of IRAK1 mRNA CTD PMID:19549813 corn oil increases expression EXP 6480464 Corn Oil results in increased expression of IRAK1 mRNA CTD PMID:33263755 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Lipopolysaccharides results in increased degradation of IRAK1 protein] CTD PMID:16678799 curcumin multiple interactions ISO IRAK1 (Homo sapiens) 6480464 Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of IRAK1 mRNA] CTD PMID:23452621 cyclosporin A increases expression ISO IRAK1 (Homo sapiens) 6480464 Cyclosporine results in increased expression of IRAK1 mRNA CTD PMID:20106945 cyclosporin A increases phosphorylation EXP 6480464 Cyclosporine results in increased phosphorylation of IRAK1 protein CTD PMID:23958496 deoxynivalenol multiple interactions EXP 6480464 deoxynivalenol inhibits the reaction [lipopolysaccharide and Escherichia coli O111 B4 results in increased phosphorylation of IRAK1 protein] CTD PMID:26961612 dextran multiple interactions EXP 6480464 [Dextrans co-treated with ferrite analog] results in decreased expression of IRAK1 mRNA CTD PMID:26576301 dextran sulfate multiple interactions EXP 6480464 [Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of IRAK1 protein CTD PMID:34273909 diarsenic trioxide decreases expression ISO IRAK1 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of IRAK1 mRNA CTD PMID:23911876 dibutyl phthalate increases expression ISO Irak1 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in increased expression of IRAK1 mRNA CTD PMID:21266533 dioxygen multiple interactions ISO IRAK1 (Homo sapiens) 6480464 3 more ... CTD PMID:23452621 dioxygen increases expression ISO IRAK1 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of IRAK1 mRNA CTD PMID:23452621 doxorubicin increases expression ISO IRAK1 (Homo sapiens) 6480464 Doxorubicin results in increased expression of IRAK1 mRNA CTD PMID:29803840 enalapril multiple interactions ISO IRAK1 (Homo sapiens) 6480464 [Atorvastatin co-treated with Enalapril] results in decreased expression of IRAK1 mRNA CTD PMID:20524934 enzyme inhibitor multiple interactions ISO IRAK1 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of IRAK1 protein CTD PMID:23301498 erlotinib hydrochloride multiple interactions ISO IRAK1 (Homo sapiens) 6480464 [Erlotinib Hydrochloride results in decreased susceptibility to Erlotinib Hydrochloride] which results in decreased expression of IRAK1 mRNA CTD PMID:27738319 ethanol multiple interactions EXP 6480464 acanthoic acid inhibits the reaction [Ethanol results in increased expression of IRAK1 protein] CTD PMID:28964808 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of IRAK1 mRNA CTD PMID:30319688 ethanol increases expression EXP 6480464 Ethanol results in increased expression of IRAK1 mRNA and Ethanol results in increased expression of IRAK1 protein CTD PMID:28964808 and PMID:30319688 fenamidone increases expression EXP 6480464 fenamidone results in increased expression of IRAK1 mRNA CTD PMID:27029645 fenthion increases expression EXP 6480464 Fenthion results in increased expression of IRAK1 mRNA CTD PMID:34813904 finasteride increases expression ISO Irak1 (Rattus norvegicus) 6480464 Finasteride results in increased expression of IRAK1 mRNA CTD PMID:24136188 flavonoids increases expression ISO IRAK1 (Homo sapiens) 6480464 Flavonoids results in increased expression of IRAK1 mRNA CTD PMID:15465739 flutamide increases expression ISO Irak1 (Rattus norvegicus) 6480464 Flutamide results in increased expression of IRAK1 mRNA CTD PMID:24136188 folic acid multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of IRAK1 mRNA] CTD PMID:22206623 folic acid increases expression ISO IRAK1 (Homo sapiens) 6480464 Folic Acid results in increased expression of IRAK1 mRNA CTD PMID:28752528 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of IRAK1 mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO IRAK1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of IRAK1 gene CTD PMID:31601247 Fusaric acid decreases expression ISO IRAK1 (Homo sapiens) 6480464 Fusaric Acid results in decreased expression of IRAK1 protein CTD PMID:30582969 genistein multiple interactions ISO IRAK1 (Homo sapiens) 6480464 Genistein inhibits the reaction [Oxygen deficiency results in increased expression of IRAK1 mRNA] CTD PMID:23452621 ginsenoside Re multiple interactions EXP 6480464 ginsenoside Re inhibits the reaction [Lipopolysaccharides results in increased degradation of IRAK1 protein] and ginsenoside Re inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IRAK1 protein] CTD PMID:22849695 glafenine increases expression ISO Irak1 (Rattus norvegicus) 6480464 Glafenine results in increased expression of IRAK1 mRNA CTD PMID:24136188 glyburide multiple interactions ISO Irak1 (Rattus norvegicus) 6480464 Glyburide inhibits the reaction [Streptozocin results in increased expression of IRAK1 protein] CTD PMID:36504472 glycyrrhetinate multiple interactions EXP 6480464 Glycyrrhetinic Acid inhibits the reaction [[lipopolysaccharide and Escherichia coli O111 B4 co-treated with Galactosamine] promotes the reaction [TRAF6 protein binds to IRAK1 protein]] CTD PMID:28213090 glycyrrhetinic acid multiple interactions EXP 6480464 Glycyrrhetinic Acid inhibits the reaction [[lipopolysaccharide and Escherichia coli O111 B4 co-treated with Galactosamine] promotes the reaction [TRAF6 protein binds to IRAK1 protein]] CTD PMID:28213090 helenalin multiple interactions EXP 6480464 helenalin inhibits the reaction [Lipopolysaccharides results in increased degradation of IRAK1 protein] CTD PMID:16678799 hydrogen peroxide affects expression ISO IRAK1 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of IRAK1 mRNA CTD PMID:20044591 hydroquinone decreases expression ISO IRAK1 (Homo sapiens) 6480464 hydroquinone results in decreased expression of IRAK1 mRNA CTD PMID:30090394 ivermectin decreases expression ISO IRAK1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of IRAK1 protein CTD PMID:32959892 kaempferol multiple interactions ISO IRAK1 (Homo sapiens) 6480464 kaempferol inhibits the reaction [IL1B protein results in increased ubiquitination of IRAK1 protein] and kaempferol inhibits the reaction [Lipopolysaccharides results in increased ubiquitination of IRAK1 protein] CTD PMID:30769083 leflunomide increases expression ISO Irak1 (Rattus norvegicus) 6480464 leflunomide results in increased expression of IRAK1 mRNA CTD PMID:24136188 lipoarabinomannan multiple interactions EXP 6480464 lipoarabinomannan inhibits the reaction [IRAK1 protein binds to TRAF6 protein] CTD PMID:16263713 lipopolysaccharide increases degradation ISO IRAK1 (Homo sapiens) 6480464 Lipopolysaccharides results in increased degradation of IRAK1 protein CTD PMID:17053167 lipopolysaccharide increases ubiquitination ISO IRAK1 (Homo sapiens) 6480464 Lipopolysaccharides results in increased ubiquitination of IRAK1 protein CTD PMID:30769083 lipopolysaccharide multiple interactions ISO IRAK1 (Homo sapiens) 6480464 kaempferol inhibits the reaction [Lipopolysaccharides results in increased ubiquitination of IRAK1 protein] CTD PMID:30769083 lipopolysaccharide multiple interactions ISO Irak1 (Rattus norvegicus) 6480464 [Lipopolysaccharides co-treated with Titanium] results in decreased expression of IRAK1 mRNA CTD PMID:21308757 lipopolysaccharide increases degradation EXP 6480464 Lipopolysaccharides results in increased degradation of IRAK1 protein CTD PMID:15933225 more ... lipopolysaccharide increases activity EXP 6480464 Lipopolysaccharides results in increased activity of IRAK1 protein CTD PMID:21276822 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of IRAK1 mRNA CTD PMID:25890327 lipopolysaccharide increases phosphorylation ISO IRAK1 (Homo sapiens) 6480464 Lipopolysaccharides results in increased phosphorylation of IRAK1 protein CTD PMID:17053167 lipopolysaccharide increases phosphorylation EXP 6480464 Lipopolysaccharides results in increased phosphorylation of IRAK1 protein CTD PMID:22849695 lipopolysaccharide multiple interactions EXP 6480464 3 more ... CTD PMID:16678799 more ... lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of IRAK1 mRNA CTD PMID:25843059 malathion increases expression ISO IRAK1 (Homo sapiens) 6480464 Malathion results in increased expression of IRAK1 mRNA CTD PMID:32069766 methidathion affects expression EXP 6480464 methidathion affects the expression of IRAK1 mRNA CTD PMID:34813904 methotrexate increases expression ISO IRAK1 (Homo sapiens) 6480464 Methotrexate results in increased expression of IRAK1 mRNA CTD PMID:21678067 Monobutylphthalate increases expression EXP 6480464 monobutyl phthalate results in increased expression of IRAK1 protein CTD PMID:32738922 Monobutylphthalate affects expression EXP 6480464 monobutyl phthalate affects the expression of IRAK1 mRNA CTD PMID:32738922 Monobutylphthalate increases ubiquitination EXP 6480464 monobutyl phthalate results in increased ubiquitination of IRAK1 protein CTD PMID:32738922 N-methyl-4-phenylpyridinium increases expression ISO IRAK1 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of IRAK1 mRNA CTD PMID:24810058 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions EXP 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of IRAK1 mRNA more ... CTD PMID:19840844 nefazodone increases expression ISO Irak1 (Rattus norvegicus) 6480464 nefazodone results in increased expression of IRAK1 mRNA CTD PMID:24136188 nicotine multiple interactions EXP 6480464 [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:20230807 nimesulide increases expression ISO Irak1 (Rattus norvegicus) 6480464 nimesulide results in increased expression of IRAK1 mRNA CTD PMID:24136188 o-anisidine decreases expression ISO IRAK1 (Homo sapiens) 6480464 2-anisidine results in decreased expression of IRAK1 mRNA CTD PMID:28089782 obeticholic acid decreases expression ISO IRAK1 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of IRAK1 mRNA CTD PMID:27939613 okadaic acid multiple interactions EXP 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of IRAK1 mRNA CTD PMID:19840844 ozone multiple interactions ISO IRAK1 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of IRAK1 mRNA CTD PMID:35430440 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of IRAK1 mRNA CTD PMID:17562736 paracetamol decreases expression ISO IRAK1 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of IRAK1 mRNA CTD PMID:21420995 and PMID:26690555 paraquat multiple interactions EXP 6480464 rhyncophylline inhibits the reaction [Paraquat results in increased phosphorylation of IRAK1 protein] and TOLLIP protein promotes the reaction [rhyncophylline inhibits the reaction [Paraquat results in increased phosphorylation of IRAK1 protein]] CTD PMID:33838153 paraquat increases phosphorylation EXP 6480464 Paraquat results in increased phosphorylation of IRAK1 protein CTD PMID:33838153 pentachlorophenol increases expression EXP 6480464 Pentachlorophenol results in increased expression of IRAK1 mRNA CTD PMID:23892564 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IRAK1 mRNA CTD PMID:19840844 phorbol 13-acetate 12-myristate multiple interactions ISO IRAK1 (Homo sapiens) 6480464 IRAK1 mutant form inhibits the reaction [[Vitallium analog co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CXCL8 mRNA] and IRAK1 mutant form inhibits the reaction [[Vitallium analog co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of CXCL8 protein] CTD PMID:23680697 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of IRAK1 mRNA CTD PMID:18301758 potassium chromate decreases expression ISO IRAK1 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of IRAK1 mRNA CTD PMID:22714537 progesterone increases expression ISO IRAK1 (Homo sapiens) 6480464 Progesterone results in increased expression of IRAK1 mRNA CTD PMID:17701593 quercetin decreases expression ISO IRAK1 (Homo sapiens) 6480464 Quercetin results in decreased expression of IRAK1 mRNA CTD PMID:23727915 resveratrol multiple interactions ISO Irak1 (Rattus norvegicus) 6480464 resveratrol inhibits the reaction [lipopolysaccharide and E coli O55-B5 results in increased expression of IRAK1 protein] CTD PMID:20035708 resveratrol multiple interactions ISO IRAK1 (Homo sapiens) 6480464 resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of IRAK1 mRNA] CTD PMID:23452621 resveratrol decreases expression ISO Irak1 (Rattus norvegicus) 6480464 resveratrol results in decreased expression of IRAK1 protein CTD PMID:20035708 Rhynchophylline multiple interactions EXP 6480464 rhyncophylline inhibits the reaction [Paraquat results in increased phosphorylation of IRAK1 protein] and TOLLIP protein promotes the reaction [rhyncophylline inhibits the reaction [Paraquat results in increased phosphorylation of IRAK1 protein]] CTD PMID:33838153 rotenone increases expression ISO IRAK1 (Homo sapiens) 6480464 Rotenone results in increased expression of IRAK1 mRNA CTD PMID:29955902 silicon dioxide increases expression ISO IRAK1 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of IRAK1 mRNA CTD PMID:25895662 silver atom increases expression ISO IRAK1 (Homo sapiens) 6480464 Silver results in increased expression of IRAK1 mRNA CTD PMID:22342292 silver(0) increases expression ISO IRAK1 (Homo sapiens) 6480464 Silver results in increased expression of IRAK1 mRNA CTD PMID:22342292 sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of IRAK1 mRNA CTD PMID:30953684 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of IRAK1 mRNA CTD PMID:31233874 streptozocin increases expression ISO Irak1 (Rattus norvegicus) 6480464 Streptozocin results in increased expression of IRAK1 protein CTD PMID:36504472 streptozocin multiple interactions ISO Irak1 (Rattus norvegicus) 6480464 Glyburide inhibits the reaction [Streptozocin results in increased expression of IRAK1 protein] and Tropisetron inhibits the reaction [Streptozocin results in increased expression of IRAK1 protein] CTD PMID:36504472 sunitinib increases expression ISO IRAK1 (Homo sapiens) 6480464 Sunitinib results in increased expression of IRAK1 mRNA CTD PMID:31533062 T-2 toxin increases expression ISO IRAK1 (Homo sapiens) 6480464 T-2 Toxin results in increased expression of IRAK1 mRNA CTD PMID:34581912 tacrolimus hydrate increases phosphorylation EXP 6480464 Tacrolimus results in increased phosphorylation of IRAK1 protein CTD PMID:23958496 telmisartan multiple interactions ISO IRAK1 (Homo sapiens) 6480464 [Atorvastatin co-treated with Telmisartan] results in decreased expression of IRAK1 mRNA CTD PMID:20524934 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of IRAK1 mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of IRAK1 mRNA CTD PMID:31919559 titanium atom multiple interactions ISO Irak1 (Rattus norvegicus) 6480464 [Lipopolysaccharides co-treated with Titanium] results in decreased expression of IRAK1 mRNA CTD PMID:21308757 titanium dioxide increases expression ISO IRAK1 (Homo sapiens) 6480464 titanium dioxide results in increased expression of IRAK1 mRNA CTD PMID:22342292 triptonide decreases expression EXP 6480464 triptonide results in decreased expression of IRAK1 mRNA CTD PMID:33045310 tropisetron multiple interactions ISO Irak1 (Rattus norvegicus) 6480464 Tropisetron inhibits the reaction [Streptozocin results in increased expression of IRAK1 protein] CTD PMID:36504472 Tylophorine increases expression ISO IRAK1 (Homo sapiens) 6480464 tylophorine analog results in increased expression of IRAK1 mRNA CTD PMID:19284764 valdecoxib increases expression ISO Irak1 (Rattus norvegicus) 6480464 valdecoxib results in increased expression of IRAK1 mRNA CTD PMID:24136188 valproic acid increases methylation ISO IRAK1 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of IRAK1 gene CTD PMID:29154799 valproic acid decreases expression ISO IRAK1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of IRAK1 mRNA CTD PMID:19101580 more ... valproic acid affects expression ISO IRAK1 (Homo sapiens) 6480464 Valproic Acid affects the expression of IRAK1 mRNA CTD PMID:25979313 vorinostat decreases expression ISO IRAK1 (Homo sapiens) 6480464 vorinostat results in decreased expression of IRAK1 mRNA CTD PMID:27188386 xanthones multiple interactions EXP 6480464 Xanthones inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased ubiquitination of and results in increased degradation of IRAK1 protein] CTD PMID:21232528 zinc oxide multiple interactions EXP 6480464 Zinc Oxide analog promotes the reaction [OVAL protein results in increased expression of IRAK1 protein] CTD PMID:25127755 zinc protoporphyrin multiple interactions ISO Irak1 (Rattus norvegicus) 6480464 zinc protoporphyrin promotes the reaction [IRAK1 protein binds to MYD88 protein] CTD PMID:25780291